News
-
-
PRESS RELEASE
Successful capital increase for a total amount of EUR12.8m, with the support of Fermentalg's industrial partner HuvePharma and Bpifrance, to create the European champion for microalgae fermentation solutions
Fermentalg successfully completes €12.8 million capital increase to support 2024-2026 strategic plan and strengthen its position as a leader in sustainable marine microalgae solutions -
-
PRESS RELEASE
Launch of a capital increase open to institutional and retail investors for a total of approximately EUR12 million, with the support of HuvePharma, Fermentalg's industrial partner
Fermentalg announces a €12 million capital increase with support from HuvePharma to lead in microalgae fermentation solutions. Sales targets raised amidst strong growth momentum. Funds to achieve financial equilibrium by 2026 -
-
-
-
-
-